SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-18-000922
Filing Date
2018-12-12
Accepted
2018-12-12 17:59:40
Documents
1
Period of Report
2018-12-10

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 16773
  Complete submission text file 0000905148-18-000922.txt   18083
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 MCKINNEY AVE SUITE 2125 DALLAS TX 75201
Business Address
Traweek James W JR (Reporting) CIK: 0001665299 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 181231728